Xiangxue Pharmaceutical (300147.SZ) announces a forecasted net loss of 600 million to 862 million yuan for the year 2024, with an expanded loss.

Xiangxue Pharmaceutical (300147.SZ) announced its performance forecast for 2024, with an estimated net loss of 6 billion to 8.62 billion yuan attributable to shareholders of the listed company, indicating an expanded loss. After deducting non-recurring gains and losses, the net loss is estimated to be 5.71 billion to 8.34 billion yuan, also indicating an increased loss.